tp-508
Peptideexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT00131482)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ThrombinACTIVATOR
F2 activator
Chemistry & pharmacology
Loading structure…
SMILES
CC(=O)O.CC(=O)O.CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)C(N)=O- Mol. weight
- 2431.58 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107369 ↗
Also known as
- chrysalin
- chrysalin
- chrysalin
- chrysalin
- chrysalin
- rusalatide acetate
- rusalatide acetate
- rusalatide acetate
- rusalatide acetate
- thrombin peptide tp508
- tp508
- tp 508
- tp-508
- tp-508
- tp-508
- tp-508 acetate
- trap-508
- trap-508
- trap-508 acetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00131482 | Phase 2 | Nov 1, 2004 | Capstone Therapeutics |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capstone Therapeutics | For profit | 1 | 1 | 1 | 2004 |
1 organizations
Page 1 / 1